Nuclear experts weigh in on medical isotopes act

01/29/2012 | Center for Public Integrity, The

Medical and nuclear nonproliferation experts have written a letter to Congress expressing concern that the American Medical Isotopes Production Act of 2011, intended to reduce the use of highly enriched uranium in producing the medical isotope molybdenum-99, could unintentionally encourage the manufacturing of such uranium. SNM's Robert Atcher said everyone agrees the use of highly enriched uranium should be cut, but any shortage in medical isotopes could limit essential medical tests unless the U.S. can make certain that domestic production can meet demand.

View Full Article in:

Center for Public Integrity, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC